SEC Filings | AcelRx Pharmaceuticals, Inc.

SEC Filings

Filing date	Description	Form	View
Nov 30, 2023	EFFECT	EFFECT	View HTML 9999999995-23-003509.pdf 9999999995-23-003509.rtf 9999999995-23-003509.xls
Nov 22, 2023	Securities offered to employees pursuant to employee benefit plans	S-8	View HTML 0001437749-23-032902.pdf 0001437749-23-032902.rtf 0001437749-23-032902.xls
Nov 22, 2023	Simplified registration form	S-3	View HTML 0001437749-23-032903.pdf 0001437749-23-032903.rtf 0001437749-23-032903.xls
Nov 14, 2023	Quarterly report which provides a continuing view of a company's financial position	10-Q	View HTML 0001437749-23-031742.pdf 0001437749-23-031742.rtf 0001437749-23-031742.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Nov 08, 2023	Report of unscheduled material events or corporate event	8-K	View HTML 0001437749-23-030955.pdf 0001437749-23-030955.rtf 0001437749-23-030955.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Oct 20, 2023	Report of unscheduled material events or corporate event	8-K	View HTML 0001437749-23-028683.pdf 0001437749-23-028683.rtf 0001437749-23-028683.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Oct 10, 2023	Report of unscheduled material events or corporate event	8-K	View HTML 0001437749-23-027971.pdf 0001437749-23-027971.rtf 0001437749-23-027971.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Oct 05, 2023	Report of unscheduled material events or corporate event	8-K	View HTML 0001437749-23-027772.pdf 0001437749-23-027772.rtf 0001437749-23-027772.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Oct 05, 2023	Additional proxy soliciting materials - definitive	DEFA14A	View HTML 0001437749-23-027777.pdf 0001437749-23-027777.rtf 0001437749-23-027777.xls
Sep 22, 2023	Report of unscheduled material events or corporate event	8-K	View HTML 0001437749-23-026612.pdf 0001437749-23-026612.rtf 0001437749-23-026612.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Data provided by Kaleidoscope.